Vigafyde
Payments companies reported to CMS as associated with Vigafyde. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vigafyde, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vigafyde
These are the largest totals companies reported as associated with Vigafyde. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Katherine Labiner | Austin, TX | Epilepsy | $345.76 |
| Daniel Gustkey | Austin, TX | Epilepsy | $276.26 |
| Karen Keough | Austin, TX | Epilepsy | $222.36 |
| Paul Maertens | Mobile, AL | Neurology With Special Qualifications In Child Neurology | $211.00 |
| Shelly Reardon | Austin, TX | Neurology With Special Qualifications In Child Neurology | $188.33 |
| Rafael Villalobos-Nieto | Harlingen, TX | Neurodevelopmental Disabilities (Pediatrics) | $147.02 |
| Lisa Calvo | Chapel Hill, NC | Neurology With Special Qualifications In Child Neurology | $145.22 |
| Kristin Fritch | Tampa, FL | Nurse Practitioner | $145.21 |
| Jose Ferreira | Tampa, FL | Neurology With Special Qualifications In Child Neurology | $111.58 |
| Riddhi Patel | El Paso, TX | Pediatrics | $106.02 |
Prescribed Vigafyde?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.